Recent Updates
Recently added Catalysts
AHCO Positive Sentiment Score: 70/100

AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health

Key Takeaway: AdaptHealth Corp. has announced the divestiture of its Diabetes Health business to Cardinal Health for $235 million in cash. This strategic move, finalized on July 19, 2026, allows AdaptHealth to concentrate on its primary offerings in home medical equipment and related services. The transaction reflects a significant shift in AdaptHealth's business strategy.
Price reaction · baseline $10.98 (2026-07-20 close) · hit after-hours · clean, no other AHCO news in the window
day 0 close
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • AdaptHealth is streamlining its operations by divesting a non-core business.
  • The sale to Cardinal Health is valued at $235 million, indicating strong market interest.
  • This move may enhance AdaptHealth's focus on its core healthcare-at-home solutions.

Full Press Release Details

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it is divesting its Diabetes Health business to Cardinal Health. Under the terms of an agreement signed July 19, 2026, Cardinal Health will acquire AdaptHealth's Diabetes Health business for $235 million in cash, subject to

Frequently Asked Questions

What business is AdaptHealth divesting?

AdaptHealth is divesting its Diabetes Health business.

Who is acquiring AdaptHealth's Diabetes Health business?

Cardinal Health is acquiring the Diabetes Health business.

What is the value of the divestiture?

The divestiture is valued at $235 million in cash.

When was the agreement signed?

The agreement was signed on July 19, 2026.

Last updated: Jul 20, 2026